CD73 is often expressed in the bone marrow, tumors, endothelial cells, etc. In pancreatic cancer, ovarian cancer, and glioblastoma, patients with high CD73 expression exhibited a prognosis worse than that exhibited by patients with low CD73 expression (166–168). Here, NT5E is linked to ovarian cancer.